SCHEMBL4283203

SCHEMBL4283203

COc1ccc(C(=O)c2c(O)cc(C)cc2F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
GAA P10253 2/20 0.47
POLB P06746 1/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
RAB9A P51151 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
HPGD P15428 1/20 0.46
CA2 P00918 3/20 0.46
CA1 P00915 2/20 0.46
PARP1 P09874 1/20 0.46
PARP10 Q53GL7 1/20 0.46
PARP2 Q9UGN5 1/20 0.46
PARP4 Q9UKK3 1/20 0.46
CYP2C19 P33261 2/20 0.46
NPC1 O15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38661406 0.88 CYP2D6 (0.54) MEN1KMT2AGAAALDH1A1LMNA
SCHEMBL4280994 0.84 PARP10 (0.50) KMT2AGAAPOLBALDH1A1LMNA
SCHEMBL4292209 0.84 MAPT (0.51) KMT2AALDH1A1LMNAMAPTMAPK1
SCHEMBL4293769 0.83 CYP3A4 (0.56) MEN1KMT2AGAAPOLBALDH1A1
SCHEMBL4280964 0.82 SLC5A1 (0.47) ALDH1A1LMNAMAPTMAPK1RAB9A
SCHEMBL4292221 0.82 MEN1 (0.54) MEN1KMT2AGAAPOLBALDH1A1
SCHEMBL4283897 0.82 HPGD (0.54) MEN1KMT2AGAAPOLBALDH1A1
SCHEMBL4287006 0.81 NFKB1 (0.46) MEN1KMT2AGAAALDH1A1LMNA
SCHEMBL4287208 0.81 BACE1 (0.49) MEN1KMT2AGAAALDH1A1LMNA
SCHEMBL8132899 0.79 MKNK2 (0.52) KMT2AGAAPOLBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 MEN1 3776/4885KMT2A 1397/4885GAA 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.